醋酸乌利司他降低子宫肌瘤患者血清与肿瘤组织中转化生长因子β3浓度
该回顾性队列研究纳入141例患者,比较未激素治疗的子宫肌瘤患者、醋酸乌利司他治疗3个月的子宫肌瘤患者及对照组的血清和肌瘤组织TGF-β3浓度。UPA组血清与组织TGF-β3均值均显著低于未治疗组,TGF-β3浓度与年龄、BMI无显著相关性。作者认为TGF-β3降低可能是UPA作用于肌瘤生物学的重要环节,需进一步研究。
要点
- UPA组血清TGF-β3均值10.88±7.15 pg/mL,低于未治疗组32.24±34.55 pg/mL。
- UPA组组织TGF-β3均值99.99±60.63 pg/mg,低于未治疗组171.29±91.81 pg/mg。
- TGF-β3浓度与年龄、BMI均无统计学显著相关性。
核心结论
- 子宫肌瘤患者血清和组织TGF-β3浓度降低可能是UPA影响肌瘤生物学的重要环节。
- 作者认为该领域需进一步研究。
研究设计与样本
- 回顾性队列研究,在大学教学医院开展,共纳入141例患者,分为子宫肌瘤未用UPA组、子宫肌瘤UPA组和对照组。
- 干预包括病史与查体、生殖道超声、血液与组织取样,以及血清和组织TGF-β3浓度测定。
- 主要结局指标为UPA治疗3个月、年龄和BMI对血清及肌瘤组织TGF-β3水平的影响。
主要发现
- 血清TGF-β3均值:未用UPA组32.24±34.55 pg/mL,UPA组10.88±7.15 pg/mL,对照组11.97±10.30 pg/mL。
- 组织TGF-β3均值:未用UPA组171.29±91.81 pg/mg,UPA组99.99±60.63 pg/mg。
- UPA治疗患者的血清和组织TGF-β3均值统计学显著低于未用UPA组。
- TGF-β3浓度与年龄或BMI之间未发现统计学显著相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate and compare transforming growth factor β3 (TGF-β3) serum concentration in patients with uterine fibroids (UFs) without hormone treatment, treated with ulipristal acetate (UPA), and controls; to evaluate TGF-β3 concentrations in UF tissue in patients without hormone treatment and those treated with UPA; and to evaluate the correlations of age and body mass index (BMI) with TGF-β3 serum and UF tissue levels between the groups. DESIGN: Retrospective cohort study. SETTING: University teaching hospital. PATIENT(S): A total of 141 patients divided into three groups: UFs non-UPA, UFs, and UPA, controls. INTERVENTION(S): Medical history and examination, genital ultrasound scan, blood and tissue sampling, and measurement of TGF-β3 serum and tissue concentrations. MAIN OUTCOME MEASURE(S): Evaluation of the impact of UPA (3 months treatment), age and BMI on TGF-β3 serum and UF tissue levels. RESULT(S): The values of TGF-β3 serum and tissue concentrations statistically significantly differed between the non-UPA and UPA groups. The mean TGF-β3 serum concentrations were non-UPA group 32.24 ± 34.55 pg/mL, UPA group 10.88 ± 7.15 pg/mL, and controls 11.97 ± 10.30 pg/mL. The mean TGF-β3 tissue concentrations were non-UPA group 171.29 ± 91.81 pg/mg and UPA group 99.99 ± 60.63 pg/mg. Statistically significantly lower mean TGF-β3 serum and tissue concentrations were observed in patients treated with UPA. No statistically significant correlations between TGF-β3 concentrations and age or BMI were found. CONCLUSION(S): Reduction of serum and tissue TGF-β3 concentrations in UFs may be an important component of the effect of UPA on UF biology. Further research in this area is necessary.
引用
- Ciebiera M, Włodarczyk M, Wrzosek M, et al. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids. Fertil Steril. 2018. PMID: 29525690. doi:10.1016/j.fertnstert.2017.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。